Tansna Featured at Epilepsy Foundation Pipeline Conference
Presentation highlights Tansna’s innovative approach to anticonvulsant therapy
Tansna President Mark Robbins, J.D., Ph.D., was invited to speak at the Epilepsy Foundation’s 2016 Pipeline Conference on February 25, 2016. A part of the foundation’s Epilepsy Therapy Project, the Pipeline Conference brings together thought leaders in the field of epilepsy treatment, therapeutic innovation, and product development. Dr. Robbins’s presentation was entitled, “Novel, Non-Sedating Propofol-Based Anticonvulsants,” and described the company’s recent progress in the development of a potentially safe and effective new anticonvulsant drug.